Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.

Saved in:
Bibliographic Details
Title: Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.
Authors: Evdokimova V; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada. Electronic address: v.evdokimova@gmail.com., Ruzanov P; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Gassmann H; Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing and Institute of Pathology, 80804 Munich, Germany; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, 80804 Munich, Germany., Hung M; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Zhang Z; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Senff-Ribeiro A; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Khoshgoo N; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Zheng S; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Pachva MC; Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Ringwalt EM; Center for Childhood Cancer, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA., Cripe TP; Center for Childhood Cancer, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA; Division of Pediatric Hematology, Oncology, and BMT, Nationwide Children's Hospital, Columbus, OH 43205, USA., Roberts RD; Center for Childhood Cancer, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA; Division of Pediatric Hematology, Oncology, and BMT, Nationwide Children's Hospital, Columbus, OH 43205, USA., Sorensen PH; Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Burdach SEG; Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing and Institute of Pathology, 80804 Munich, Germany; CCC München Comprehensive Cancer Center, DKTK German Cancer Consortium Munich, 80804 Munich, Germany., Stein LD; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada., Radvanyi L; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Cancer Research Program, Ottawa Health Research Institute, and Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8L6, Canada; Department of Immunology, University of Toronto, Toronto, ON M5S 1A1, Canada. Electronic address: lradvanyi@ohri.ca.
Source: Cell reports [Cell Rep] 2026 Jul 21; Vol. 45 (7), pp. 117708. Date of Electronic Publication: 2026 Jul 21.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2211-1247
DOI:10.1016/j.celrep.2026.117708